BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $320 | $419 | $526 | $234 |
| - Cash | $114 | $112 | $64 | $44 |
| + Debt | $59 | $78 | $59 | $52 |
| Enterprise Value | $265 | $386 | $521 | $242 |
| Revenue | $167 | $156 | $111 | $56 |
| % Growth | 6.5% | 40.5% | 100.2% | – |
| Gross Profit | $143 | $132 | $90 | $40 |
| % Margin | 86% | 84.2% | 80.6% | 71.6% |
| EBITDA | $45 | $40 | $13 | -$18 |
| % Margin | 26.7% | 25.9% | 11.3% | -31.9% |
| Net Income | $85 | $26 | -$15 | -$34 |
| % Margin | 50.9% | 16.4% | -13.7% | -60.9% |
| EPS Diluted | 0.82 | 0.24 | -0.18 | -0.54 |
| % Growth | 241.7% | 233.3% | 66.7% | – |
| Operating Cash Flow | $41 | $25 | $11 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$2 |
| Free Cash Flow | $41 | $25 | $11 | -$26 |